Insurances & Business

Progenics stock leaps as drug wins approval

Investment | Sources: LoHUD

Similar/Related/News:

• Beacon Power Wins Environmental Approval to Build 20 MW Flywheel Plant in Stephentown, New York (Business Wire)
TYNGSBORO, Mass.----Beacon Power Corporation , a company that designs and develops advanced products and services to support more stable, reliable and...
• FDA Says Glaxo Failed to Report Avandia Data
WASHINGTON (Reuters) - GlaxoSmithKline Plc <GSK.L> <GSK.N> failed to report all of the required post-approval data on its diabetes dru...
• Merck shares fall on FDA drug rejection, Abbott shares rise (AP)
Merck & Co. shares fell Tuesday after the Food and Drug Administration rejected the drugmaker's cholesterol drug Cordaptive, marking the company's sec...
• Novartis shares jump as cancer drug shows promise (AP)
Shares of drug developer Novartis AG jumped Monday after the company said its kidney cancer drug candidate delayed tumor growth twice as long as place...
• Discovery shares plunge on delay for key drug candidate (AP)
Discovery Laboratories Inc. shares plunged Friday after its key drug candidate faced another regulatory delay with the Food and Drug Administration, f...
• Cephalon shares fall ahead of FDA panel on pain drug Fentora (AP)
Cephalon Inc. shares fell Friday over concerns that the biotechnology company may face a tougher-than-expected Food and Drug Administration panel revi...
• "L" is For Loews — Tisch Family Wins Coveted Ticker
BANGALORE (Reuters) - Loews Corp <LTR.N>, the conglomerate run by the billionaire Tisch family, on Monday said it will change its New York S...
• Out of the Gate: QLT climbs after RBC upgrades (AP)
Shares of QLT Inc. rose Thursday after an RBC Capital Markets analyst upgraded the drug maker, saying it is underpriced given a recent divestiture and...